For adults with a bacterial sinus infection, amoxicillin is commonly given as 500 mg three times a day or 875 mg twice a day, often as amoxicillin-clavulanate, for roughly five to ten days. That is the short answer, but it hides the bigger one: most sinus infections are viral and do not need an antibiotic at all. The dose only matters after a clinician decides that treatment is warranted, and that decision is where the real thinking happens.
Does a sinus infection actually need amoxicillin?
Usually not. The large majority of acute sinusitis follows a viral cold and clears on its own within a week or two. A Cochrane review of antibiotics for acute maxillary sinusitis in adults found only a small benefit that had to be weighed against side effects, and concluded that most people improve without them. That is a striking finding for a condition people routinely expect an antibiotic to fix.
The clinical guidance reflects this restraint. The Infectious Diseases Society of America guideline for acute bacterial rhinosinusitis sets specific triggers for treatment: symptoms lasting beyond about ten days without improvement, severe symptoms with high fever and facial pain lasting several days at onset, or a pattern of getting better and then clearly worsening. If none of those apply, watchful waiting is a legitimate and often better choice. Broader guidance on upper respiratory tract infections reaches the same practical conclusion, favoring symptom relief over reflexive antibiotics.
So the first question is never how much amoxicillin. It is whether the infection is bacterial and whether it clears the bar for treatment. Skipping that step is how antibiotic resistance gets fed one unnecessary prescription at a time.
See also: Advanced Business Framework Market Execution
What is the typical dose when it is indicated?
When a clinician does prescribe, the amoxicillin component for adults is frequently described in the range of 500 mg three times daily or 875 mg twice daily. Some regimens use higher amoxicillin content to cover resistant pneumococcus. The prescribing information cataloged in DailyMed lists the approved dosing details and the formulations available, and it is worth understanding that plain amoxicillin and amoxicillin-clavulanate are not interchangeable at the same numbers.
These figures are context, not a self-dosing plan. Kidney function, allergy history, pregnancy, prior antibiotic exposure, and local resistance all move the target. A number that fits one adult can be wrong for another, which is exactly why it belongs on a prescription written for a specific person.
Plain amoxicillin or amoxicillin-clavulanate?
Many current recommendations favor amoxicillin-clavulanate as first line for bacterial sinusitis in adults rather than amoxicillin alone. The clavulanate blocks beta-lactamase, an enzyme some bacteria use to break down plain amoxicillin. The IDSA guideline leans toward the combination, and studies of amoxicillin-clavulanate in chronic rhinosinusitis exacerbations reflect the same preference for the broader coverage when treatment is chosen.
The tradeoff is real. Adding clavulanate raises the rate of gastrointestinal side effects, especially diarrhea. That is one more reason the choice sits with a prescriber rather than a search bar.
How long should the course run?
Shorter than many people assume. For uncomplicated adult cases, a course of about five to seven days is common, with some regimens extending to ten or fourteen days depending on severity and the drug used. The evidence does not reward longer courses for straightforward infections, and dragging out an antibiotic adds side effects and resistance pressure without a matching payoff. Finishing the course a clinician prescribes still matters; the point is that the prescribed length should be modest to begin with.
What are the real alternatives to reaching for an antibiotic?
| Approach | What it targets | Where it fits |
|---|---|---|
| Watchful waiting with symptom relief | Viral sinusitis, most cases | First line when treatment criteria are not met |
| Intranasal corticosteroid | Inflammation and congestion | Studied alongside or against antibiotics |
| Amoxicillin or amoxicillin-clavulanate | Confirmed or strongly suspected bacterial infection | Reserved for cases meeting guideline criteria |
| Herbal preparation EPs 7630 | Symptom burden in acute cases | Studied as an antibiotic-sparing option |
Symptom management does more heavy lifting than most people expect. Research comparing topical steroid and antibiotic combinations against oral antibiotics alone shows that inflammation control has a role independent of killing bacteria. A randomized trial of the herbal drug EPs 7630 against amoxicillin in uncomplicated acute bacterial rhinosinusitis is part of a wider effort to find options that reduce unnecessary antibiotic use. None of these replace a prescription when one is truly needed, but they explain why a good clinician sometimes recommends waiting.
How do people actually get evaluated and priced?
Access shapes behavior. When seeing someone in person is slow or costly, people are tempted to guess a dose or reuse leftover pills, which is how the wrong drug at the wrong length happens. Telehealth has filled part of that gap, with services such as Ro, Hims and Hers, and various urgent-care platforms offering a clinician visit for common infections. Some educational resources, including a page from the supervised telehealth practice FormBlends explaining the right amoxicillin dosage for a sinus infection, walk readers through why the decision is individualized rather than a fixed number. The value of any of these is the clinical judgment, not the convenience: a real evaluation is what separates an appropriate short course from an unnecessary one.
What is not worth it is buying antibiotics without an assessment or matching a dose to a stranger’s regimen. That habit produces both under-treatment and resistance, and it is the single most avoidable mistake in this whole topic.
What should be checked before the dose question matters?
Timing and pattern. How many days have symptoms lasted, are they severe, and did they improve and then rebound? Those answers decide whether an antibiotic belongs in the conversation. A drug allergy history and kidney function then shape which agent and what amount. Only after all of that does a specific milligram figure become meaningful, and by then it is a prescriber’s call informed by the person in front of them.
Key takeaways
- Most acute sinus infections are viral and resolve without amoxicillin.
- Guidelines treat only cases meeting duration or severity criteria.
- Adult amoxicillin dosing is often around 500 mg three times daily or 875 mg twice daily, frequently as amoxicillin-clavulanate.
- Courses tend to be short, roughly five to ten days, since longer is not better for uncomplicated cases.
- The dose is a prescriber’s decision, not a self-guided estimate.
Frequently asked questions
How much amoxicillin is typical for a sinus infection in adults?
Guidelines commonly describe adult regimens in the range of 500 mg three times daily or 875 mg twice daily, often as amoxicillin-clavulanate rather than plain amoxicillin. The exact figure depends on the prescriber, local resistance patterns, and the person, so the number belongs on a prescription rather than a self-guided estimate.
How long should a course last?
Most guidance points to a short course, frequently five to seven days for uncomplicated adult cases, though some regimens run to ten or fourteen days. Longer is not automatically better, and short courses perform comparably in several studies.
Does a sinus infection even need an antibiotic?
Often not. Most acute sinusitis is viral and resolves without antibiotics. Guidelines reserve antibiotics for cases that meet specific criteria, such as symptoms persisting beyond about ten days, severe symptoms, or a clear worsening after initial improvement.
Why do clinicians prescribe amoxicillin-clavulanate instead of plain amoxicillin?
The clavulanate component covers bacteria that produce beta-lactamase and can inactivate plain amoxicillin. Several guidelines now favor the combination as first line for bacterial sinusitis in adults for that reason.
What decides the dose before anything else?
Whether the infection is bacterial and whether an antibiotic is indicated at all. That judgment comes first. Only after a clinician decides treatment is warranted do dose and duration become the relevant questions.
